Picture of KoBioLabs logo

348150 KoBioLabs Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
Consumer DefensivesHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for KoBioLabs, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-15,382-23,030-14,683-4,178-6,945
Depreciation
Amortisation
Non-Cash Items6564,609-3,063-2,176-1,072
Unusual Items
Other Non-Cash Items
Changes in Working Capital2,0139582,398-580-545
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-12,481-16,556-13,832-4,355-5,784
Capital Expenditures-5,551-14,765-15,562-1,646-553
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-25,603-47,04923,7548,08110,001
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-31,154-61,8148,1926,4349,448
Financing Cash Flow Items-9.89-7.480
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities55,74136,3104,046-6,513-3,386
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash12,066-42,260-386-4,358-1,095